Takeda Pharmaceutical Company Limited American Depositary Shares (each r (TAK) Covered Calls
You can sell covered calls on Takeda Pharmaceutical Company Limited American Depositary Shares (each r to lower risk and earn monthly income. Born To Sell's covered call screener gives you customized search capabilities across all possible covered calls but here are a couple of examples for TAK (prices last updated Wed 12:10 PM ET):
| Takeda Pharmaceutical Company Limited American Depositary Shares (each r (TAK) Stock Quote | ||||||
|---|---|---|---|---|---|---|
| Last | Change | Bid | Ask | Volume | P/E | Market Cap |
| 18.18 | +0.10 | 18.18 | 18.19 | 1.1M | - | 0.0 |
| Covered Calls For Takeda Pharmaceutical Company Limited American Depositary Shares (each r (TAK) | ||||||
|---|---|---|---|---|---|---|
| Expiration | Strike | Call Bid | Net Debit | Return If Flat |
Annualized Return If Flat |
|
| Mar 20 | 17.5 | 0.75 | 17.44 | 0.3% | 6.4% | |
| Apr 17 | 17.5 | 0.85 | 17.34 | 0.9% | 7.3% | |
| Subscribers get access to the full covered call chain, and more features. | ||||||
Want to make money with covered calls? Sign Up For A Free Trial
Extended Business Description
Takeda Pharmaceutical Company Limited engages in the research, development, manufacturing, and marketing of pharmaceutical products, over-the-counter medicines and quasi-drug consumer products, and other healthcare products. It offers pharmaceutical products in the areas of gastroenterology; oncology; neuroscience; and rare diseases, such as rare metabolic and hematology, and heredity angioedema, as well as plasma-derived therapies and vaccines. The company provides its products under the ENTYVIO, GATTEX/REVESTIVE, ALOFISEL, NATPARA, ADYNOVATE/ADYNOVI, TAKHZYRO, ELAPRASE, VPRIV, GAMMAGARD LIQUID/KIOVIG, HYQVIA, CUVITRU, ALBUMIN/FLEXBUMIN, NINLARO, and ALUNBRIG brands. It operates in Japan, the United States, Europe and Canada, Russia/CIS, Latin America, rest of Asia, the Middle East, Oceania, and Africa. The company has licensing agreements with TESARO, Inc., Denali Therapeutics, and Wave Life Sciences Ltd; collaboration agreements with Rani Therapeutics LLC, Novimmune S.A., AB Biosciences Inc., Sosei Group Corporation, and LogicBio Therapeutics, Inc.; strategic collaboration with Prometheus Biosciences, Inc; a license and research agreement with The University of Texas MD Anderson Cancer Center; a research collaboration agreements with Enzyre BV and Cerevance; a collaboration agreement with Artisan Bio, Inc.; and a multi-target rare disease collaboration with Evox Therapeutics Ltd., as well as licensing agreement with ProThera Biologics Inc. It also has a corporate strategic research alliance with Egle Therapeutics SAS; a strategic partnership with Neurocrine Biosciences, Inc.; Carmine Therapeutics and HemoShear Therapeutics, LLC. Takeda Pharmaceutical Company Limited was founded in 1781 and is headquartered in Tokyo, Japan.
| Top 10 Open Interest For Mar 20 Expiration | Top 5 High Yield | |||||
|---|---|---|---|---|---|---|
| 1. | NVDA covered calls | 6. | EWZ covered calls | 1. | STUB covered calls | |
| 2. | SLV covered calls | 7. | QQQ covered calls | 2. | RGTI covered calls | |
| 3. | EEM covered calls | 8. | GLD covered calls | 3. | MRVL covered calls | |
| 4. | IBIT covered calls | 9. | FXI covered calls | 4. | CMPX covered calls | |
| 5. | SPY covered calls | 10. | KWEB covered calls | 5. | CIEN covered calls | |
Want more examples? TAIL Covered Calls | TAL Covered Calls
